Azeria Therapeutics

About:

Azeria Therapeutics is a developer of a cancer drug intended to aid in the treatment of breast and prostate cancer patients.

Website: https://www.azeriatherapeutics.com

Top Investors: Sixth Element Capital, Syncona Partners LLP

Description:

Azeria Therapeutics is a developer of a cancer drug intended to aid in the treatment of breast and prostate cancer patients. The company develops a pipeline of small molecules designed to selectively inhibit pioneer factors, enabling medical professionals to treat cancer patients.

Total Funding Amount:

36M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)azeriatherapeutics.com

Founders:

Jason Carroll

Number of Employees:

11-50

Last Funding Date:

2019-11-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai